They definitely hope to have some FDA patient data (as late breaking) to present at the November London Valves conference. Could be the 3 month progress update for the FDA EFS patients but will also include data from the Tbilisi patients.
It will be tight and will depend on when the FDA approves the start of the EFS trial. This could be any day and is imminent (although that means different things in FDA timelines so who knows when). I am hoping by the end of June.
DYOR and Not advice.
They definitely hope to have some FDA patient data (as late...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$6.27 |
Change
0.360(6.09%) |
Mkt cap ! $97.17M | |||
| Open | High | Low | Value | Volume |
| $5.93 | $6.30 | $5.91 | $107.9K | 17.39K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3500 | $6.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.27 | 200 | 1 |
View Market Depth
| Last trade - 15.42pm 27/06/2025 (20 minute delay) ? |
| AVR (ASX) Chart |